By Scientia Professor John Martin Kaldor

Journal articles

Grulich AE; Cunningham PH; Munier CM; Prestage G; Amin J; Ringland C; Whitby D; Kippax SC; Kaldor JM; Rawlinson WD, 2005, 'Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia.', Sexual Health, 2, pp. 13 - 18

Vajdic CM; Middleton MG; Bowden F; Fairley CK; Kaldor JM, 2005, 'The prevalence of genital Chlamydia trachomatis in Australia 1997-2004: a systematic review.', Sexual Health, 2, pp. 169 - 183

Van De Ven PG; Mao L; Fogarty A; Rawstorne PR; Crawford J; Prestage G; Grulich AE; Kaldor JM; Kippax SC, 2005, 'Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney', AIDS, 19, pp. 179 - 184

Turner J; Hughes AM; Kricker A; Milliken ST; Grulich AE; Kaldor JM; Armstrong BK, 2005, 'WHO non-Hodgkin's lymphoma classification by criterion-based report review followed by targeted pathology review: An effective strategy for epidemiology studies.', Cancer epidemiology biomarkers and prevention, 14, pp. 2213 - 2219

Van De Ven PG; Mao L; Crawford J; Prestage G; Grulich AE; Kaldor JM; Kippax SC, 2005, 'Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia', International Journal of STD and AIDS, 16, pp. 314 - 317

Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6

Bugeja MJ; Booth DR; Bennetts BH; Guerin J; Kaldor JM; Stewart GJ, 2004, 'Analysis of the CCL3-L1 gene for association with HIV-1 susceptibility and disease progression', AIDS, 18, pp. 1069 - 1071, http://dx.doi.org/10.1097/00002030-200404300-00017

Grulich AE; Vajdic CM; Kaldor JM; Hughes AN; Kricker A; Fritschi L; Turner J; Milliken ST; Benke G; Armstrong BK, 2004, 'Birth order, atopy, and risk of non-Hodgkin lymphoma', Blood, 104, pp. 384A - 384A

Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber P; Marinos G; Levy MH; Kaldor JM; Dolan K; Ffrench R; Lloyd AR; Rawlinson WD, 2004, 'Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort', Journal of Infectious Diseases, 189, pp. 1846 - 1855

Jauncey ME; Micallef JM; Gilmour S; Amin J; White PA; Rawlinson WD; Kaldor JM; Van Beek IA; Dore GJ, 2004, 'Clearance of hepatitis C virus after newly acquired infection ininjection drug users', Journal of Infectious Diseases, 190, pp. 1270 - 1274

Robotin M; Law MG; Milliken ST; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE, 2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin`s lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, 5, pp. 377 - 384

O Sullivan BG; Gidding H; Law MG; Kaldor JM; Gilbert GL; Dore GJ, 2004, 'Estimates of chronic hepatitis B virus infection in Australia, 2000', Australian and New Zealand Journal of Public Health, 28, pp. 212 - 216

O'Sullivan BG; Gidding HF; Law M; Kaldor JM; Gilbert GL; Dore GJ, 2004, 'Estimates of chronic hepatitis B virus infection in Australia, 2000', Australian and New Zealand Journal of Public Health, 28, pp. 212 - 216, http://dx.doi.org/10.1111/j.1467-842x.2004.tb00477.x

Fin F; Prestage G; Pell CM; Donovan BJ; Van der ven P; Kippax SC; Kaldor JM; Grulich AE, 2004, 'Hepatitis A and B infection and vaccination in a cohort of homosexual men in Sydney, Australia', Sexual Health, 1, pp. 227 - 237

Jin F; Prestage G; Pell CM; Donovan BJ; Van De Ven PG; Kippax SC; Kaldor JM; Grulich AE, 2004, 'Hepatitis A and hepatitis B infection and vaccination in a cohort of homosexual men in Sydney', Sexual Health, 1, pp. 227 - 237

Amin J; Gidding HF; Gilbert GL; Backhouse J; Kaldor JM; Dore GJ; Burgess MA, 2004, 'Hepatitis C prevalence - a nationwide serosurvey', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 28, pp. 517 - 521

Hughes A; Armstrong BK; Vajdic CM; Turner J; Grulich AE; Fritschi L; Milliken ST; Kaldor JM; Benke G; Kricker A, 2004, 'Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma', International Journal of Cancer, 110, pp. 429 - 434

Sullivan EA, 2004, 'Prevalence of sexually transmitted diseases and human immunodeficiency virus among women attending prenatal services in Apia,Samoa', International Journal STD and AIDS, 15, pp. 116 - 119

Butler TG; Kariminia A; Levy MT; Kaldor JM, 2004, 'Prisoners are at risk for hepatitis C transmission', European Journal of Epidemiology, 19, pp. 1119 - 1122

Stafford JA; Post JJ; Kaldor JM; Pan Y; Haber P; Lloyd AR; Dolan K, 2004, 'Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 81, pp. 448 - 452, http://dx.doi.org/10.1093/jurban/jth129

Hughes A; Armstrong BK; Vajdic CM; Turner J; Grulich AE; Fritschi L; Milliken ST; Kaldor JM; Benke G; Kricker A, 2004, 'Sun exposure may protect against non-Hodgkin lymphoma: A case-controlstudy', International Journal of Cancer, 112, pp. 865 - 871

Robotin M; Copland J; Tallis G; Coleman D; Giele C; Carter L; Spencer J; Kaldor JM; Dore GJ, 2004, 'Surveillance for newly acquired hepatitis C in Australia', Journal of Gastroenterology and Hepatology, 19, pp. 283 - 288

Turner J; Hughes AM; Kricker A; Milliken ST; Grulich AE; Kaldor JM; Armstrong BK, 2004, 'Use of the WHO lymphoma classification in a population-based epidemiological study', Annals of Oncology, 15, pp. 631 - 637, http://www.sciencedirect.com/science/article/B6WVB-4C7NNW9-19W/2/fe877418c0bb9f98703ef22c1660fe82

Graves N; Walker DW; McDonald AM; Kaldor JM; Ziegler JB, 2004, 'Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevelance? Modelling the data for Australia', Journal of Infectious Diseases, 190, pp. 166 - 175

Porter K; Law M; Dabis F; Thiebaut R; Chêne G; Lawson-Ayayi S; Meyer L; Boufassa F; Hamouda O; Fischer K; Pezzotti P; Rezza G; Touloumi G; Hatzakis A; Karafoulidou A; Katsarou O; Brettle R; Del Amo J; del Romero J; van Asten L; van Benthem B; Prins M; Coutinho R; Kirk O; Pedersen C; Hernández Aguado I; Pérez-Hoyos S; Eskild A; Bruun JN; Sannes M; Sabin C; Lee C; Johnson AM; Phillips AN; Babiker A; Darbyshire JH; Gill N; Porter K; Francioli P; Vanhems P; Egger M; Rickenbach M; Cooper D; Kaldor J; Ashton L; Vizzard J; Muga R; Day NE; De Angelis D, 2003, 'Estimating the effect of antiretroviral treatment during HIV seroconversion: Impact of confounding in observational data', HIV Medicine, 4, pp. 332 - 337, http://dx.doi.org/10.1046/j.1468-1293.2003.00168.x

Sullivan EA; Abel M; Tabrizi S; Garland SM; Grice A; Poumerol G; Taleo H; Chen S; Kaun K; O'Leary M; Kaldor J, 2003, 'Prevalence of sexually transmitted infections among antenatal women in Vanuatu, 1999-2000', Sexually Transmitted Diseases, 30, pp. 362 - 366, http://dx.doi.org/10.1097/00007435-200304000-00017

Dore GJ; MacDonald M; Law MG; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia.', Australian family physician, 32, pp. 796 - 798

Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM, 2003, 'Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok', Southeast Asian Journal of Tropical Medicine and Public Health, 34, pp. 804 - 809

MICALLEF J; JAUNCEY M; AMIN J; RAWLINSON W; GILMOUR S; VANBEEK I; KALDOR J; WHITE P; DORE G, 2003, '229 Hepatitis C virus reinfection within a cohort of injecting drug users', Hepatology, 38, pp. 266 - 266, http://dx.doi.org/10.1016/s0270-9139(03)80272-0

Blumer C; Roche P; Spencer J; Lin M; Milton A; Bunn C; Gidding HF; Kaldor JM; Kirk M; Hall R; Della-Porta T; Leader R; Wright P, 2003, 'Australia's notifiable diseases status, 2001: annual report of the National Notifiable Diseases Surveillance System', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 27, pp. 1 - 78

Butler TG; Levy MH; Dolan K; Kaldor JM, 2003, 'Drug use and its correlates in an Australian prison population', Addiction Research and Theory, 11, pp. 89 - 101

MacDonald MA; Law MG; Kaldor JM; Hales J; Dore GJ, 2003, 'Effectiveness of needle and syringe programmes for preventing HIV transmission', International Journal of Drug Policy, 14, pp. 353 - 357

Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench R, 2003, 'Effector HIV-specific cytotoxic T lymphocyte activity in HIV non-progressors correlates with viral replication and progression', Journal of Medical Virology, 71, pp. 483 - 491

Dore GJ; Law MG; MacDonald MA; Kaldor JM, 2003, 'Epidemiology of hepatitis C virus infection in Australia', Journal of Clinical Virology, 26, pp. 171 - 184

O Sullivan BG; Levy MH; Dolan K; Post JJ; Barton SG; Dwyer D; Kaldor JM; Grulich AE, 2003, 'Hepatitis C transmission and HIV post-exposure prophylaxis after needle-and syringe-sharing in Australian prisons', Medical Journal of Australia, 178, pp. 546 - 549

Miller J; Carr AD; Emery S; Law MG; Mallal SS; Baker D; Smith DG; Kaldor JM; Cooper DA, 2003, 'HIV lipodystrophy: prevalence, severity and correlates of risk in Australia', HIV Medicine, 4, pp. 293 - 301

Kaldor JM; McDonald AM, 2003, 'HIV/AIDS surveillance systems in Australia', Journal of Acquired Immune Deficiency Syndrome, 32, pp. 18 - 23

French MA; Herring BL; Kaldor JM; Sayer DC; Furner V; Chaneet CC; Dwyer DE, 2003, 'Intrafamilial transmission of HIV 1 infection from individuals with unrecognised HIV 1 Infection', AIDS, 17, pp. 1977 - 1981

McDonald AM; Li Y; Dore GJ; Ree H; Kaldor JM, 2003, 'Late HIV presentation among AIDS cases in Australia, 1992-2001', Australian and New Zealand Journal of Public Health, 27, pp. 608 - 613

Dore GJ; McDonald AM; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 17, pp. 1539 - 1545

Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor JM; Loveday S; Powell E; Spencer J; Wodak AD, 2003, 'Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001', International Journal of Epidemiology, 32, pp. 717 - 724

Dore GJ; Freeman A; Law MG; Kaldor JM, 2003, 'Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings', Antiviral Therapy, 8, pp. 365 - 372

Kaldor J, 2003, 'Obituary-Margaret MacDonald 1956–2003', International Journal of Drug Policy, 14, pp. 349 - 349, http://dx.doi.org/10.1016/j.drugpo.2003.10.002

Freeman A; Law MG; Kaldor JM; Dore GJ, 2003, 'Predicting progression to cirrhosis in chronic hepatitis C virus infection', Journal of Viral Hepatitis, 10, pp. 285 - 293

Spencer J; Tibbits D; Tippet C; Mead C; Kaldor JM; Dore GJ, 2003, 'Review of antenatal testing policies and pratice for HIV and hepatitis C infection', Australian and New Zealand Journal of Public Health, 27, pp. 614 - 619

Kippax SC; Slavin SF; Ellard JM; Hendry O; Richters J; Grulich AE; Kaldor JM, 2003, 'Seroconversion in context', AIDS Care - Psychological and Socio - Medical Aspects of AIDS/HIV, 15, pp. 839 - 852

Murray JM; Law MG; Gao Z; Kaldor JM, 2003, 'The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users', International Journal of Epidemiology, 32, pp. 708 - 714, http://ije.oxfordjournals.org/content/32/5/708.abstract

Kimber J; MacDonald MA; Van Beek IA; Kaldor JM; Weatherburn D; Lapsley HM; Mattick RP, 2003, 'The Sydney Medically Injecting Centre : Client Characteristics and Predictors of Frequent Attendance Druing the First 12 Months of Operation', Journal of Drug Issues, 33, pp. 639 - 648

Collins S; Boyd A; Lee JS; Lewis V; Fletcher A; McLean CA; Law M; Kaldor J; Smith MJ; Masters CL, 2002, 'Creutzfeldt-Jakob disease in Australia 1970-1999', Neurology, 59, pp. 1365 - 1371, http://dx.doi.org/10.1212/01.WNL.0000031793.11602.8C

Dore GJ; Freeman AJ; Kaldor JM; Post JJ; Harvey CE; Ffrench RA; Lloyd AR; Mehta SH; Cox AL; Strathdee SA; Vlahov D; Thomas DL, 2002, 'Immunity against hepatitis C virus infection [2] (multiple letters)', Lancet, 360, pp. 1019 - 1020, http://dx.doi.org/10.1016/s0140-6736(02)11102-0

Back to profile page